InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Kariuki Enoch, Director. Director active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 4 reports have been recorded. History available since 8 June 2022. The latest transaction was filed on 17 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Enoch Kariuki is a Board Member at Zentalis Pharmaceuticals, Inc. He is involved in overseeing operations and the strategic direction of the company. With his industry experience, he makes significant contributions to decisions influencing the future of Zentalis. His role is crucial in ensuring the organization's growth and sustainability.